Alexander Skokan, MD
Urology · Seattle, WANPI 1851719900
Payments from drug & device makers
What this record shows
This record is dominated by education: $6,000 of the $9,417 with a category attached, or 63.7%. Intuitive Surgical accounts for 71.2% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2021 at $6,014 and has fallen 94.1% since, to $356 in 2025.
Across 53 payments — averaging $177.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$7K
- Boston Scientific$2K
- Medtronic$377
- Kerecis Limited$188
- Coloplast$126
- LSI Solutions Inc$120
- plus $136 from 3 others
What the payments were for
- Travel & lodging$1,43415%
- Food & beverage$1,98321%
- Education$6,00064%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 6 | $6,709 |
| Boston Scientific | 33 | $1,761 |
| Medtronic | 6 | $377 |
| Kerecis Limited | 2 | $188 |
| Coloplast | 1 | $126 |
| LSI Solutions Inc | 1 | $120 |
| Baxter Healthcare | 2 | $88 |
| Endo Pharmaceuticals Inc. | 1 | $28 |
| Innovation Technologies Inc | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$6,676
- AMS$867
- Kerecis SurgiClose$584
- INTERSTIM$220
- Kerecis GraftGuide$146
- TITAN$126
- JNW URTRAC$120
How this compares
$9,417 in reported general payments places this provider in the 85th percentile of 274 urology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trospium Chloride ErTrospium Chloride | 12 | $739 |
| Oxybutynin Chloride ErOxybutynin Chloride | 40 | $430 |
| Tamsulosin Hcl | 14 | $117 |
| Oxycodone Hcl | 12 | $101 |
| Ibuprofen | 17 | $81 |
| Oxybutynin Chloride | 14 | $78 |
Paid to pharmacies, not to this prescriber.
Other urology in Seattle
- James PorterSeattle$471K
- Marah HehemannSeattle$213K
- Thomas WalshSeattle$186K
- Alvaro LucioniSeattle$148K
- Una LeeSeattle$116K
- George SchadeSeattle$78K
- Vi NguyenSeattle$53K
- Rogerio HuangSeattle$45K
- Cristopher GarlitzSeattle$45K
- Sarah PsutkaSeattle$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.